Abstract:BACKGROUND:von Wil ebrand factor-A1 (VWF-A1) plays a crucial role in primary hemostasis by mediating blood platelet adhesion to sites of vascular damage under conditions of high shear stress. However, mostly expression of recombinant VWF-A1 in form of inclusion bodied within Escherichia coli (E. coli) that is not conducive to purify and functional study in vitro. <br> OBJECTIVE:To acquire soluble recombinant VWF-A1 including wild type and its mutation G1324S which can be stable efficiently expressed in E. coli and to verify their biological function. <br> METHODWild-type VWF-A1 and its mutation G1324S recombinant plasmids were transformed into competent cells DH5α, to screen and extract the plasmids. Then the extracted plasmids were respectively transformed into E. coli BL21 and E. coli M15, to screen monoclonal bacterium. The bacterium was cultured in LB culture medium. The bacteria breaking methods with lysozyme and with ultrasonic were compared. Then, the solubilized proteins were passed over Ni-NTA agarose column to purify the VWF-A1 protein, and the purity and immune activity of purified products were identified with SDS-PAGE and western blot analysis. Final y, the biological function of the purified proteins was assessed by their ability to support flow-dependent platelet adhesion by paral el-plate flow chamber system. <br> RESULTS AND CONCLUSION:We obtained about 5.77 mg VWF-A1, 6.83 mg VWF-G1324S in culture supernatants per 100 mil iliter, respectively, which al showed high purity and immune activity. The data of flow chamber experiment demonstrated that both VWF-A1 and VWF-G1324S could mediate platelet adhesion. As the shear stress increased from 0.1 Pa to 1 Pa, the decline (46.8%) of the number of adhesive cells in G1324S mutation group was higher than that of wild type group (20.5%). This evidence indicated that, the A1 molecule functions were attenuated after mutation. Our research shows that, wild type of VWF-A1 showed a stronger interaction with platelet in shear stress, which is consistent with clinical characteristics.

[Expression of Von Willebrand Factor-A3 Domain in E Coli and Its Biological Function].

[Eukaryotic Expression of Von Willebrand Factor A1A2A3 Triplet and Its Biological Activity].

[A2 Domain of Human Von Willebrand Factor Expressed in E. Coli and Its Biological Activity].

Molecular Cloning of Human Vwf/a1 Gene and Its Expression

Soluble expression and function of von Willebrand factor-A1 in Escherichia coli

Expression, Purification and Characterization of Recombinant Human Coagulation Factor XIIIa in Pichia Pastoris

Role and mechanism of Leptospira interrogans vWF-A gene products binding to human collagen proteins

Generation and characterization of a recombinant single chain Fv antibody to von Willebrand factor A1 domain from phage display library.

Characterization and Functional Studies of Vwf A3 Domain Monoclonal Antibodies That Inhibit Binding of Vwf to Collagen

Production and Characterization of Novel Neutralizing Mabs Against Vwf-A3 Domain, an Inhibitor of Binding of Vwf to Collagen and Influence of Interaction Between Vwf and Platelet GPIbα.

Gene Expression and Activity Analysis of a Novel Fusion Protein (Rgd)3/ttf

[Expression of Platelet Collagen Receptor-Glycoprotein VI Fragment in E. Coli and Its Biological Activities].

Recombination Expression and Cytolytic Bioactivity of vvhA Fusion Protein:Cytolysin of V.vulnificus

Expression, characterization and antivascular activity of amino acid sequence repeating collagen hexadecapeptide

Study of expression in Chinese hamster ovary cells and function of recombinant active fragment of glycoprotein IbαH1-V289

[Expression of the Metalloproteinase Domain of Von Willebrand Factor-Cleaving Protease and Preparation of Its McAb].

[Stable Expression and Characterization of the Von Willebrand Factor Cleaving Protease].

Cloning and expression of the metalloproteinase domain of human von Willebrand factor-cleaving protease

[Expression of Vwf73 and VWF114 Fragments of Von Willebrand Factor A2 Domain and Their Utilization in Detecting ADAMTS13 Activity].

Purification and Functional Characterization of Two Thrombosis-Related Molecules: Von Willebrand Factor and ADAMTS-13

Expression and Function Identification of Extracellular Domain 3 of Human Vascular Endothelial Growth Factor Receptor KDR